Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing compound doai
Reexamination Certificate
2011-05-10
2011-05-10
Loewe, Sun Jae Y (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing compound doai
C564S305000
Reexamination Certificate
active
07939569
ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
REFERENCES:
patent: 2004/0266856 (2004-12-01), Chu et al.
patent: 2004058679 (2004-07-01), None
patent: 2006058648 (2006-06-01), None
Yamaguchi et al., caplus an 2008:476100.
Bolin David Robert
Hamilton Matthew Michael
Hoffmann-La Roche Inc.
Johnston George W.
Loewe Sun Jae Y
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Aniline analogs as glycogen synthase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aniline analogs as glycogen synthase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aniline analogs as glycogen synthase activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672734